This Barrier-Breaking Pharma Executive Is Surprisingly Optimistic About Increasing Diversity In STEM
Forbes Leadership
SEPTEMBER 9, 2022
She's also aiming to increase the number of women and minorities in senior roles in the UK and US to 30% by the end of 2025. As President of GlaxoSmithKline (GSK) in the US, she oversees the company’s complex portfolio of therapeutics.
Let's personalize your content